| RS1047201601 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS1047229701 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS1047233939 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
HUWE1-related disorder, Inborn genetic diseases |
| RS1047322213 |
PQBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Renpenning syndrome, PQBP1-related disorder |
| RS1047332996 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS1047334468 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS1047344623 |
SLC24A5
|
Health Risk |
Pathogenic |
— |
| RS1047347414 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
DICER1-related tumor predisposition, Hereditary cancer-predisposing syndrome |
| RS1047348249 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1047376 |
ABCA4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1047396806 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1047420796 |
TRIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation deficiency 35, Inborn genetic diseases |
| RS1047426224 |
ETFA
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Glutaric acidemia type 2A |
| RS1047485135 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1047486988 |
ALDH7A1
|
Health Risk |
Likely pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1047501521 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS1047509819 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 13 |
| RS1047531932 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1047569721 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1047596402 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS1047608955 |
RNF168
|
Health Risk |
Likely pathogenic |
RIDDLE syndrome, RIDDLE syndrome |
| RS1047644991 |
F8
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of coagulation, Hereditary factor VIII deficiency disease |
| RS1047677628 |
SDHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 3 |
| RS1047677696 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1047718058 |
DUOX2
|
Health Risk |
Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS1047747 |
ALG1
|
Health Risk |
Likely pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1047795344 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS1047808762 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1047810495 |
SLC22A5
|
Health Risk |
Pathogenic |
Renal carnitine transport defect, Renal carnitine transport defect |
| RS1047838051 |
NSD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1047872625 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Jeune thoracic dystrophy |
| RS1047910260 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1047937861 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS1047955739 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1047976958 |
SLC22A12
|
Health Risk |
Conflicting classifications of pathogenicity |
Dalmatian hypouricemia, SLC22A12-related disorder |
| RS1048000119 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1048018914 |
PUS1
|
Health Risk |
Pathogenic |
Myopathy, lactic acidosis |
| RS1048022444 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1048025807 |
PCDH12
|
Health Risk |
Pathogenic |
Diencephalic-mesencephalic junction dysplasia syndrome 1, Diencephalic-mesencephalic junction dysplasia syndrome 1 |
| RS1048032321 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1048042 |
CEP152
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 9, primary |
| RS1048086299 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1048095 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Permanent neonatal diabetes mellitus, Neonatal diabetes mellitus |
| RS1048095040 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1048096626 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS1048099 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1048122979 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1048183757 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1048199759 |
HNRNPK
|
Health Risk |
Conflicting classifications of pathogenicity |
Au-Kline syndrome, Au-Kline syndrome |
| RS1048233904 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Inborn genetic diseases |
| RS1048241141 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cerebral palsy |
| RS1048273373 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1048322333 |
HINT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive axonal neuropathy with neuromyotonia, Inborn genetic diseases |
| RS1048376563 |
OPA1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1048427417 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Coffin-Siris syndrome 1 |
| RS1048433974 |
SATB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1048444597 |
PLA2G6
|
Health Risk |
Pathogenic |
Infantile neuroaxonal dystrophy, PLA2G6-associated neurodegeneration |
| RS1048452849 |
IFNAR1
|
Health Risk |
Likely pathogenic |
— |
| RS1048457038 |
CRPPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1048485136 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Oligodontia-cancer predisposition syndrome |
| RS1048529437 |
PADI6
|
Health Risk |
Likely pathogenic |
Preimplantation embryonic lethality 2, Preimplantation embryonic lethality 2 |
| RS1048545964 |
NDP
|
Health Risk |
Likely pathogenic |
— |
| RS10485741 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tetralogy of Fallot, Cardiovascular phenotype |
| RS1048593315 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked |
| RS1048609704 |
ATP2C1
|
Health Risk |
Likely pathogenic |
— |
| RS1048661 |
LOXL1
|
Health Risk |
risk factor |
Exfoliation syndrome, susceptibility to |
| RS1048666076 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Kabuki syndrome |
| RS1048708341 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS1048716809 |
MEFV
|
Health Risk |
Likely pathogenic |
Familial Mediterranean fever, Familial Mediterranean fever |
| RS1048754592 |
RDH12
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 13, Leber congenital amaurosis 13 |
| RS1048764460 |
COG4
|
Health Risk |
Pathogenic |
Delayed gross motor development, Microcephalic osteodysplastic dysplasia |
| RS1048819854 |
FSCN2
|
Health Risk |
Conflicting classifications of pathogenicity |
FSCN2-related disorder, FSCN2-related disorder |
| RS1048845848 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS104886033 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS104886035 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS104886039 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS104886040 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS104886041 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS104886043 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886047 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886050 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886054 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886056 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS104886059 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886060 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886061 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886062 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS104886063 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886065 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS104886066 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886067 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS104886068 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS104886071 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, Alport syndrome |
| RS104886073 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886074 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886076 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS104886078 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886079 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, Alport syndrome |
| RS104886080 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS104886081 |
COL4A5
|
Health Risk |
Pathogenic |
— |